<DOC>
	<DOCNO>NCT00000915</DOCNO>
	<brief_summary>The purpose study estimate rate certain population becomes infect HIV . The individual examine study people expect take part future study HIV vaccine nonvaccine HIV prevention study . This study also examine chance become HIV-positive base certain risk factor condition similar condition would exist HIV vaccine non-HIV prevention study . Before study effectiveness potential HIV vaccine , important learn range HIV risk behavior potential participant study . The probability HIV infection associate risk behavior also examine . This study design increase ability HIVNET put place HIV prevention trial , increase diversity trial participant , target population high risk HIV infection .</brief_summary>
	<brief_title>An HIV Vaccine Preparedness Study</brief_title>
	<detailed_description>Vaccine preparedness study necessary order prepare launch preventive HIV vaccine efficacy trial . It important gather information risk HIV infection among recruited population , extent stability HIV risk behavior population , risk HIV infection associate risk behavior . This vaccine preparedness study design expand capacity HIVNET implement HIV prevention trial , increase diversity participant population , target population high risk HIV infection . Participants complete total 6 schedule study visit : 2 baseline , 2 follow-up 6 month later , 2 follow-up 12 month enrollment . Participant risk behavior knowledge attitude toward HIV vaccine HIV prevention trial assess time point . HIV infection status test standard HIV ELISA Western blot follow-up , well participant request throughout study . Participants instruct recognize report suspect primary HIV infection base symptom high-risk exposure . HIV pre-test , risk reduction , post-test counseling provide accordance CDC standard practice . Participants become infected HIV study counsel refer medical psychosocial service .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria Participants meet follow criterion : HIVseronegative . Available 6 month study . ( Note : Participants plan move one study location another eligible . ) Willing able provide information locator purpose . Report one follow risk behavior : For men : Intravenous intramuscular injection drug average 3 day per week last 3 month . Anal intercourse ( receptive insertive ) one men last year . For woman : Intravenous intramuscular injection drug average 3 day per week last 3 month . Having current male sex partner infect HIV . Having current male sex partner inject drug last 5 year . Having 5 male sex partner last year . Diagnosis syphilis , chlamydia , gonorrhea , first episode herpes , pelvic inflammatory disease , and/or trichomoniasis last year . Exchange sex money drug last year . Use crack cocaine last 12 month . See General Inclusion Criteria require risk behavior . Volunteers must : HIVpositive HIVNET test HIVseronegative EIA . Presently sexual relationship least 6 month duration intention remain partner duration study . Willing identify recruit sexual partner he/she disclose disclose HIV serostatus . Willing receive counseling HIV testing ( HIVseronegative partner ) . Willing agree interview partner individually . Willing continue engage sex partner . Willing participate couplesbased condom promotion intervention . Willing able attend schedule intervention/followup study visit . Exclusion Criteria Coexisting Condition : Persons follow symptoms condition exclude : An obvious psychological psychiatric disorder would preclude provision inform consent otherwise contraindicate study participation . Any condition opinion principal investigator would interfere achieve study objective . Men risk anal intercourse exclude : Currently single HIVseronegative partner mutually monogamous relationship least 2 year . Men woman risk injection exclude : Have participate methadone drug treatment program least last 6 month . Currently obtain 50 percent needles/syringes injection drug needle exchange program . NOTE : Meeting follow extremely high injection risk criterion override exclusion criterion injection risk outline : Using needle syringe one know HIVpositive person 2 time past 3 month . Using needle syringe person unknown HIV status past 3 month provide follow two condition true : ( 1 ) report use needle syringe someone else 2 different time past 3 month ( 2 ) report use needle syringe 3 different person past 3 month . ( This second criterion could meet 3 episode injection single injection partner , participant use needle syringe different person time . Alternatively , criterion could meet single episode injection , participant use needle syringe 3 person use single set work . ) Concurrent Medication : Excluded : Enrollment HIV vaccine trial , unless approval obtain Data Management Committee Project Officer . Risk Behavior : See General Exclusion Criteria exclude risk behavior .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>AIDS Vaccines</keyword>
	<keyword>Incidence</keyword>
	<keyword>Knowledge , Attitudes , Practice</keyword>
	<keyword>Risk-Taking</keyword>
</DOC>